Triple-negative breast cancer (TNBC)11, characterized by the triple negativity of estrogen receptor (ER), progesterone receptor (PR) and HER2, is highly aggressive and shows rapid tumor growth with high incidence of metastasis, and the poor clinical outcome10,12,13. Here, ESR1 is linked to triple-negative breast carcinoma.